Remove category pharmaceuticals
article thumbnail

The Case for Procurement Transparency

Bill of Health

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.

article thumbnail

6 Ways AI is Impacting Cancer Diagnosis, Treatment and Patient Outcomes in 2024

HIT Consultant

Reshaping routine diagnostic procedures and treatment decisions and propelling pharmaceutical and research domains into new realms, AI offers significant benefits to clinicians, healthcare systems, researchers, and, most importantly, patients. This is particularly evident in cancer diagnosis and treatment across six key areas: 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Pharma Startups Can Remain Competitive in Today’s Market

HIT Consultant

In the Pharmaceutical industry, one of the major gaps is an effective, and personalized customer experience. . In addition to an increase in online shopping for essentials and home-related categories, McKinsey’s research indicates that over-the-counter (OTC) medicine purchases are expected to grow by 44% in 2020.

article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

pharmaceutical market. Senator Sanders’ proposal within PAHPA was ultimately struck from the next iteration of the legislation due to concerns from the pharmaceutical industry and others that such a measure would chill innovation. None of these instances have chilled innovation or resulted in market delays.

COVID-19 205
article thumbnail

Why Companies Need Healthcare Commercial Intelligence

HIT Consultant

Healthcare commercial intelligence is a new category of software designed to help organizations address the complexity of product development and sales in the healthcare market. He has built several research-based businesses focused on providing the highest quality and most timely data in information-intensive industries.

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. These are: Perception, Trust, Risk and the Uncertainty Produced by an Ever-Changing Context, categories that sweep in all of the issues at hand.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. The purpose of the note is to clarify that products for invasive aesthetic treatments cannot be regularized in the category of cosmetics.

FDA 52